Skip to content

Atypical Hemolytic Uremic Syndrome C2931788

Published: July 22, 2026Updated: August 20, 2026

A rare blood disorder causing red blood cell breakdown, low platelets, and kidney damage due to complement system dysregulation. Affects both children and adults. Complement inhibitors have transformed treatment outcomes.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
N28.9
ICD-11
GA00.0
Body system
renal
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Low platelet count (thrombocytopenia)

!

Headache and visual disturbances

!

Ischemic colitis

Changes in urination or swelling

(renal)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Hematuria and proteinuria

(renal)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Renal disease management

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
2

Terminal Complement Inhibition

First-line monoclonal antibody therapy blocking C5 to prevent complement-mediated microangiopathy. Revolutionized aHUS management with high response rates even in refractory cases.

medication

Additional treatment options

Plasma-Based Therapies

Therapeutic plasma exchange or fresh frozen plasma infusion to provide functional complement regulators and remove pathogenic factors.

procedure

Renal Replacement Therapy

Dialysis support for patients with severe acute kidney injury. May be temporary or ongoing depending on renal recovery.

procedure

Antihypertensive Management

Blood pressure control with ACE inhibitors or ARBs to reduce proteinuria and protect residual kidney function from further damage.

medication

Activity Modification and Fall Prevention

Appropriate activity level adjustment during acute illness with gradual return to normal function. Includes fall precautions given potential fatigue from anemia.

lifestyle

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Atypical Hemolytic Uremic Syndrome C2931788?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Goodship TH, Cook HT, Fakhouri F, et al. Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int. 2017.

guideline2017
2

Kavanagh D, Goodship TH, Richards A. Atypical hemolytic uremic syndrome, thrombotic microangiopathy, and complement-mediated conditions. Semin Nephrol. 2013.

review2013
3

Légaré PL, Ngo S, Loirat D, et al. Eculizumab in atypical hemolytic uremic syndrome: long-term clinical outcomes and transplant survival. Transpl Int. 2021.

clinical_trial2021
4

Alashkar F, Düring M, Vance C, et al. Complement inhibition in thrombotic microangiopathies: a systematic review and meta-analysis of eculizumab trials. Blood Rev. 2022.

meta_analysis2022

Medication Comparisons

Compare medications used to treat Atypical Hemolytic Uremic Syndrome C2931788. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy